These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 11738795
1. Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Seckl JR. Mol Cell Endocrinol; 2001 Dec 20; 185(1-2):61-71. PubMed ID: 11738795 [Abstract] [Full Text] [Related]
2. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Seckl JR, Cleasby M, Nyirenda MJ. Kidney Int; 2000 Apr 20; 57(4):1412-7. PubMed ID: 10760076 [Abstract] [Full Text] [Related]
3. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Seckl JR. Steroids; 1997 Jan 20; 62(1):89-94. PubMed ID: 9029721 [Abstract] [Full Text] [Related]
4. Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences. O'Regan D, Welberg LL, Holmes MC, Seckl JR. Semin Neonatol; 2001 Aug 20; 6(4):319-29. PubMed ID: 11972433 [Abstract] [Full Text] [Related]
5. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner. Reynolds RM. Psychoneuroendocrinology; 2013 Jan 20; 38(1):1-11. PubMed ID: 22998948 [Abstract] [Full Text] [Related]
6. Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring. Welberg LA, Seckl JR, Holmes MC. Eur J Neurosci; 2000 Mar 20; 12(3):1047-54. PubMed ID: 10762336 [Abstract] [Full Text] [Related]
7. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Seckl JR, Holmes MC. Nat Clin Pract Endocrinol Metab; 2007 Jun 20; 3(6):479-88. PubMed ID: 17515892 [Abstract] [Full Text] [Related]
12. Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity. Solano ME, Holmes MC, Mittelstadt PR, Chapman KE, Tolosa E. Semin Immunopathol; 2016 Nov 20; 38(6):739-763. PubMed ID: 27465226 [Abstract] [Full Text] [Related]
13. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Clark PM. Eur J Pediatr; 1998 Jan 20; 157 Suppl 1():S7-10. PubMed ID: 9462899 [Abstract] [Full Text] [Related]
14. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Bertram C, Trowern AR, Copin N, Jackson AA, Whorwood CB. Endocrinology; 2001 Jul 20; 142(7):2841-53. PubMed ID: 11416003 [Abstract] [Full Text] [Related]
15. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Lindsay RS, Lindsay RM, Waddell BJ, Seckl JR. Diabetologia; 1996 Nov 20; 39(11):1299-305. PubMed ID: 8932995 [Abstract] [Full Text] [Related]
16. Glucocorticoids, prenatal stress and the programming of disease. Harris A, Seckl J. Horm Behav; 2011 Mar 20; 59(3):279-89. PubMed ID: 20591431 [Abstract] [Full Text] [Related]
18. The Role of 11β-Hydroxy Steroid Dehydrogenase Type 2 in Glucocorticoid Programming of Affective and Cognitive Behaviours. Shearer FJG, Wyrwoll CS, Holmes MC. Neuroendocrinology; 2019 Mar 20; 109(3):257-265. PubMed ID: 30884491 [Abstract] [Full Text] [Related]